M&T Bank
BIO icon

M&T Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

M&T Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$672K Buy
2,409
+21
+0.9% +$6.05K ﹤0.01% 982
2025
Q4 		$724K Buy
2,388
+582
+32% +$182K ﹤0.01% 975
2025
Q3 		$506K Sell
1,806
-49
-3% -$13.3K ﹤0.01% 984
2025
Q2 		$447K Buy
1,855
+66
+4% +$15.6K ﹤0.01% 1116
2025
Q1 		$436K Sell
1,789
-390
-18% -$117K ﹤0.01% 1121
2024
Q4 		$716K Buy
2,179
+200
+10% +$67.9K ﹤0.01% 1026
2024
Q3 		$662K Sell
1,979
-206
-9% -$65.4K ﹤0.01% 1062
2024
Q2 		$596K Sell
2,185
-93
-4% -$27K ﹤0.01% 1045
2024
Q1 		$787K Sell
2,278
-92
-4% -$30.3K ﹤0.01% 957
2023
Q4 		$765K Sell
2,370
-124
-5% -$38.9K ﹤0.01% 969
2023
Q3 		$894K Sell
2,494
-378
-13% -$146K ﹤0.01% 876
2023
Q2 		$1.09M Sell
2,872
-157
-5% -$63.9K ﹤0.01% 837
2023
Q1 		$1.45M Buy
3,029
+236
+8% +$110K 0.01% 734
2022
Q4 		$1.17M Sell
2,793
-126
-4% -$50.9K ﹤0.01% 796
2022
Q3 		$1.22M Sell
2,919
-548
-16% -$273K 0.01% 753
2022
Q2 		$836K Buy
3,467
+1,835
+112% +$956K ﹤0.01% 832
2022
Q1 		$919K Buy
1,632
+80
+5% +$48.2K ﹤0.01% 778
2021
Q4 		$1.17M Buy
1,552
+65
+4% +$48.6K ﹤0.01% 730
2021
Q3 		$1.11M Buy
1,487
+8
+0.5% +$5.99K 0.01% 728
2021
Q2 		$953K Buy
1,479
+1
+0.1% +$609 ﹤0.01% 774
2021
Q1 		$844K Sell
1,478
-384
-21% -$227K ﹤0.01% 802
2020
Q4 		$1.09M Buy
1,862
+906
+95% +$516K ﹤0.01% 738
2020
Q3 		$493K Buy
956
+89
+10% +$45.1K ﹤0.01% 1000
2020
Q2 		$391K Sell
867
-390
-31% -$172K ﹤0.01% 1062
2020
Q1 		$441K Buy
1,257
+26
+2% +$9.56K ﹤0.01% 956
2019
Q4 		$455K Sell
1,231
-24
-2% -$8.46K ﹤0.01% 890
2019
Q3 		$419K Sell
1,255
-172
-12% -$56.1K ﹤0.01% 1030
2019
Q2 		$447K Sell
1,427
-368
-21% -$110K ﹤0.01% 1028
2019
Q1 		$549K Buy
1,795
+38
+2% +$10.3K ﹤0.01% 916
2018
Q4 		$408K Sell
1,757
-1,233
-41% -$331K ﹤0.01% 994
2018
Q3 		$937K Buy
2,990
+24
+0.8% +$7.45K ﹤0.01% 778
2018
Q2 		$855K Buy
2,966
+1,197
+68% +$331K ﹤0.01% 816
2018
Q1 		$443K Sell
1,769
-425
-19% -$108K ﹤0.01% 1054
2017
Q4 		$522K Sell
2,194
-256
-10% -$62K ﹤0.01% 986
2017
Q3 		$544K Buy
2,450
+126
+5% +$28.4K ﹤0.01% 950
2017
Q2 		$525K Buy
2,324
+467
+25% +$102K ﹤0.01% 954
2017
Q1 		$370K Sell
1,857
-1,327
-42% -$256K ﹤0.01% 1132
2016
Q4 		$580K Sell
3,184
-2,291
-42% -$391K ﹤0.01% 994
2016
Q3 		$898K Buy
5,475
+3,598
+192% +$546K 0.01% 822
2016
Q2 		$268K Buy
1,877
+5
+0.3% +$713 ﹤0.01% 1308
2016
Q1 		$256K Buy
1,872
+179
+11% +$23.5K ﹤0.01% 1351
2015
Q4 		$235K Buy
1,693
+65
+4% +$9.01K ﹤0.01% 1419
2015
Q3 		$220K Sell
1,628
-20
-1% -$2.88K ﹤0.01% 1476
2015
Q2 		$248K Sell
1,648
-27
-2% -$3.86K ﹤0.01% 1616
2015
Q1 		$226K Sell
1,675
-27
-2% -$3.35K ﹤0.01% 1665
2014
Q4 		$205K Buy
+1,702
New +$196K ﹤0.01% 1747

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

M&T Bank's BIO Position: Q1 2026 in Review

M&T Bank increased its Bio-Rad Laboratories Class A (BIO) stake by 0.88% in Q1 2026, buying an estimated $6.05K and bringing the position to 2,409 shares worth $672K. The position accounts for ﹤0.01% of the portfolio, ranked #982.

M&T Bank first reported a position in BIO in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.45M in Q1 2023. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • M&T Bank held 2,409 shares of Bio-Rad Laboratories Class A worth $672K as of Q1 2026.
  • M&T Bank bought 21 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $6.05K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #982 holding.
  • M&T Bank first reported a position in Bio-Rad Laboratories Class A in Q4 2014 and has held it in 46 quarters since.
  • M&T Bank's Bio-Rad Laboratories Class A position peaked at $1.45M in Q1 2023.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.